This report studies the Pancrelipase (CAS 53608-75-6) market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Pancrelipase is a combination of three enzymes (proteins): lipase, protease, and amylase. These enzymes are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars. Pancrelipase is used to replace these enzymes when the body does not have enough of its own. Certain medical conditions can cause this lack of enzymes, including cystic fibrosis, chronic inflammation of the pancreas, or blockage of the pancreatic ducts.
Pancrelipase is a combination of three enzymes (proteins): lipase, protease, and amylase. These enzymes are normally produced by the pancreas and are important in the digestion of fats, proteins, and sugars. According to the type, it would be made into capsule and tablet, and the capsule is the main type in the world and takes 55.92% of the global production in 2016. According to the different age stage, it can be used by children and adults.
UAS is the biggest manufacturing region in the world for Abbott is the biggest manufacturer in the world with the main factory based in USA. Europe also is a main manufacturing region for the famous company Janssen manufactures pancrelipase in Europe. Japan becomes the main manufacturing region for Abbott has its factory in Japan and some years ago Mylan signed an agreement with Abbott about Creon and other brands to expand Japanese market.
The market concentrate is high and in the world there are mainly four companies such as Abbott
, Janssen, Aptalis and DCI. Abbott is the biggest manufacturer in the world and produced 185.97 K Units, taking 37.26% of the global production.
The global Pancrelipase (CAS 53608-75-6) market was 930 million US$ in 2017 and is expected to 1260 million US$ by the end of 2025, growing at a CAGR of 4.3% between 2018 and 2025.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Pancrelipase (CAS 53608-75-6) in these regions, from 2013 to 2025, covering
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Turkey etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil etc.)
Middle East and Africa (Egypt and GCC Countries)
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include
New Hope Group
By the product type, the market is primarily split into
By the end users/application, this report covers the following segments
We can also provide the customized separate regional or country-level reports, for the following regions:
Rest of Asia-Pacific
Rest of Europe
Central & South America
Rest of Central & South America
Middle East & Africa
Rest of Middle East & Africa
The study objectives of this report are:
To study and analyze the global Pancrelipase (CAS 53608-75-6) market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Pancrelipase (CAS 53608-75-6) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pancrelipase (CAS 53608-75-6) manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pancrelipase (CAS 53608-75-6) with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Pancrelipase (CAS 53608-75-6) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Pancrelipase (CAS 53608-75-6) are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million USD) and volume (M Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pancrelipase (CAS 53608-75-6) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Raw material suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Pancrelipase (CAS 53608-75-6) market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.